Cargando…

Development of robust discriminant equations for assessing subtypes of glioblastoma biopsies

BACKGROUND: In the preceding decade, various studies on glioblastoma (Gb) demonstrated that signatures obtained from gene expression microarrays correlate better with survival than with histopathological classification. However, there is not a universal consensus formula to predict patient survival....

Descripción completa

Detalles Bibliográficos
Autores principales:	Castells, X, Acebes, J J, Majós, C, Boluda, S, Julià-Sapé, M, Candiota, A P, Ariño, J, Barceló, A, Arús, C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2012
Materias:	Molecular Diagnostics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3364559/ https://www.ncbi.nlm.nih.gov/pubmed/22568967 http://dx.doi.org/10.1038/bjc.2012.174

Ejemplares similares

Dynamics of chemosensitivity and chromosomal instability in recurrent glioblastoma
por: Spiegl-Kreinecker, S, et al.
Publicado: (2007)

ADM3, TFF3 and LGALS3 are discriminative molecular markers in fine-needle aspiration biopsies of benign and malignant thyroid tumours
por: Karger, S, et al.
Publicado: (2012)

Melanoma sentinel node biopsy and prediction models for relapse and overall survival
por: Mitra, A, et al.
Publicado: (2010)

Immunological subtypes in breast cancer are prognostic for invasive ductal but not for invasive lobular breast carcinoma
por: Engels, C C, et al.
Publicado: (2014)

Expression of cytoplasmic and nuclear Survivin in primary and secondary human glioblastoma
por: Xie, D, et al.
Publicado: (2006)

Construction of tissue microarrays from prostate needle biopsy specimens
por: Jhavar, S, et al.
Publicado: (2005)

Nuclear CSPP1 expression defined subtypes of basal-like breast cancer
por: Sternemalm, J, et al.
Publicado: (2014)

Clinical significance of CD151 overexpression in subtypes of invasive breast cancer
por: Kwon, M J, et al.
Publicado: (2012)

Autophagy inhibition induces enhanced proapoptotic effects of ZD6474 in glioblastoma
por: Shen, J, et al.
Publicado: (2013)

Identification of proteomic biomarkers predicting prostate cancer aggressiveness and lethality despite biopsy-sampling error
por: Shipitsin, M, et al.
Publicado: (2014)

Extent of MGMT promoter methylation correlates with outcome in glioblastomas given temozolomide and radiotherapy
por: Dunn, J, et al.
Publicado: (2009)

Reproductive factors and subtypes of breast cancer defined by hormone receptor and histology
por: Ursin, G, et al.
Publicado: (2005)

Molecular subtyping of DCIS: heterogeneity of breast cancer reflected in pre-invasive disease
por: Clark, S E, et al.
Publicado: (2011)

Interleukin-6 gene amplification and shortened survival in glioblastoma patients
por: Tchirkov, A, et al.
Publicado: (2007)

Validation of histomolecular classification utilizing histological subtype, MUC1, and CDX2 for prognostication of resected ampullary adenocarcinoma
por: Schueneman, A, et al.
Publicado: (2015)

MicroRNA profiles classify papillary renal cell carcinoma subtypes
por: Wach, S, et al.
Publicado: (2013)

Discriminating metastasised from non-metastasised seminoma based on transcriptional changes in primary tumours using NGS
por: Ruf, C G, et al.
Publicado: (2014)

Melatonin inhibits aromatase promoter expression by regulating cyclooxygenases expression and activity in breast cancer cells
por: Martínez-Campa, C, et al.
Publicado: (2009)

A four-kallikrein panel for the prediction of repeat prostate biopsy: data from the European Randomized Study of Prostate Cancer Screening in Rotterdam, Netherlands
por: Gupta, A, et al.
Publicado: (2010)

BCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received
por: Dawson, S-J, et al.
Publicado: (2010)

Fluorescence in-situ hybridisation on biopsies from clam ileocystoplasties and on a clam cancer
por: Ivil, K D, et al.
Publicado: (2006)

KRAS mutational subtype and copy number predict in vitro response of human pancreatic cancer cell lines to MEK inhibition
por: Hamidi, H, et al.
Publicado: (2014)

DNA methylation status is more reliable than gene expression at detecting cancer in prostate biopsy
por: Paziewska, A, et al.
Publicado: (2014)

Integrated miRNA and mRNA expression profiling of the inflammatory breast cancer subtype
por: Van der Auwera, I, et al.
Publicado: (2010)

Gene-expression data integration to squamous cell lung cancer subtypes reveals drug sensitivity
por: Wu, D, et al.
Publicado: (2013)

The G-protein-coupled formylpeptide receptor FPR confers a more invasive phenotype on human glioblastoma cells
por: Huang, J, et al.
Publicado: (2010)

Detection and prognostic significance of circulating tumour cells in patients with metastatic breast cancer according to immunohistochemical subtypes
por: Peeters, D J E, et al.
Publicado: (2014)

Immunohistochemical discrimination of wild-type EGFR from EGFRvIII in fixed tumour specimens using anti-EGFR mAbs ICR9 and ICR10
por: Modjtahedi, H, et al.
Publicado: (2012)

Intact and cleaved forms of the urokinase receptor enhance discrimination of cancer from non-malignant conditions in patients presenting with symptoms related to colorectal cancer
por: Lomholt, A F, et al.
Publicado: (2009)

Inflammation and tissue repair markers distinguish the nodular sclerosis and mixed cellularity subtypes of classical Hodgkin's lymphoma
por: Birgersdotter, A, et al.
Publicado: (2009)

A microRNA-based prediction algorithm for diagnosis of non-small lung cell carcinoma in minimal biopsy material
por: Bediaga, N G, et al.
Publicado: (2013)

Large needle aspiration biopsy and galectin-3 determination in selected thyroid nodules with indeterminate FNA-cytology
por: Carpi, A, et al.
Publicado: (2006)

CBF1 is clinically prognostic and serves as a target to block cellular invasion and chemoresistance of EMT-like glioblastoma cells
por: Maciaczyk, D, et al.
Publicado: (2017)

MYC functions are specific in biological subtypes of breast cancer and confers resistance to endocrine therapy in luminal tumours
por: Green, Andrew R, et al.
Publicado: (2016)

Combination of osteopontin and activated leukocyte cell adhesion molecule as potent prognostic discriminators in HER2- and ER-negative breast cancer
por: Ihnen, M, et al.
Publicado: (2010)

Tumour biomarker expression relative to age and molecular subtypes of invasive breast cancer
por: Morrison, D H, et al.
Publicado: (2012)

Molecular imaging of glioblastoma multiforme using anti-insulin-like growth factor-binding protein-7 single-domain antibodies
por: Iqbal, U, et al.
Publicado: (2010)

The combined endocrine receptor in breast cancer, a novel approach to traditional hormone receptor interpretation and a better discriminator of outcome than ER and PR alone
por: Campbell, Esther J, et al.
Publicado: (2016)

miR-30e* is an independent subtype-specific prognostic marker in breast cancer
por: D'Aiuto, F, et al.
Publicado: (2015)

Unraveling response to temozolomide in preclinical GL261 glioblastoma with MRI/MRSI using radiomics and signal source extraction
por: Núñez, Luis Miguel, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8u9984eb4hrt5jdv9tkrrnln0j